Cancer stem cells in osteosarcoma

被引：236
|
作者：
Brown, Hannah K. [1 ,2 ]
Tellez-Gabriel, Marta [3 ]
Heymann, Dominique [1 ,2 ,4 ]
机构：
[1] Univ Sheffield, Sch Med, Dept Oncol & Metab, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England
[2] Univ Sheffield, INSERM, European Associated Lab, Sarcoma Res Unit,Med Sch, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England
[3] Hosp Santa Creui St Pau, Inst Invest Biomed IBB St Pau, Lab Hematol Oncol & Transplantes, Barcelona 08025, Spain
[4] Univ Nantes, Fac Med, INSERM,Equipe Ligue 2012, UMR 957,Pathophysiol Bone Resorpt & Therapy Prima, F-44035 Nantes, France
来源：
CANCER LETTERS | 2017年 / 386卷
关键词：
Osteosarcoma; Bone cancer; Cancer stem cell; Tumour heterogeneity; SIDE POPULATION CELLS; DECIPHERING INTRATUMOR HETEROGENEITY; TUMOR-INITIATING CELLS; CD133; EXPRESSION; DRUG-RESISTANCE; BONE SARCOMAS; SELF-RENEWAL; SOLID TUMORS; ACTIVATION; DRIVER;
D O I：
10.1016/j.canlet.2016.11.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Osteosarcoma is the most common primary bone tumour in children and adolescents and advanced osteosarcoma patients with evidence of metastasis share a poor prognosis. Osteosarcoma frequently gains resistance to standard therapies highlighting the need for improved treatment regimens and identification of novel therapeutic targets. Cancer stem cells (CSC) represent a sub-type of tumour cells attributed to critical steps in cancer including tumour propagation, therapy resistance, recurrence and in some cases metastasis. Recent published work demonstrates evidence of cancer stem cell phenotypes in osteosarcoma with links to drug resistance and tumorigenesis. In this review we will discuss the commonly used isolation techniques for cancer stem cells in osteosarcoma as well as the identified biochemical and molecular markers. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：189 / 195
页数：7
相关论文
共 50 条
  • [31] Stem cells, cancer, and cancer stem cells
    Reya, T
    Morrison, SJ
    Clarke, MF
    Weissman, IL
    NATURE, 2001, 414 (6859) : 105 - 111
  • [32] Cells of origin in osteosarcoma: Mesenchymal stem cells or osteoblast committed cells?
    Mutsaers, Anthony J.
    Walkley, Carl R.
    BONE, 2014, 62 : 56 - 63
  • [33] Stem Cells, Cancer, and Cancer Stem Cells.
    Wahl, G. M.
    CANCER RESEARCH, 2011, 71
  • [34] Unveiling Metabolic Vulnerability and Plasticity of Human Osteosarcoma Stem and Differentiated Cells to Improve Cancer Therapy
    Della Sala, Gerardo
    Pacelli, Consiglia
    Agriesti, Francesca
    Laurenzana, Ilaria
    Tucci, Francesco
    Tamma, Mirko
    Capitanio, Nazzareno
    Piccoli, Claudia
    BIOMEDICINES, 2022, 10 (01)
  • [35] Cisplatin-resistant osteosarcoma cells possess cancer stem cell properties in a mouse model
    Yang, Jian
    Guo, Weichun
    Wang, Lu
    Yu, Ling
    Mei, Hongjun
    Fang, Shuo
    Ji, Peng
    Liu, Yang
    Liu, Gaiwei
    Song, Qi
    ONCOLOGY LETTERS, 2016, 12 (04) : 2599 - 2605
  • [36] STEM CELLS AND CANCER STEM CELLS
    Suda, Toshio
    NEURO-ONCOLOGY, 2009, 11 (06) : 872 - 872
  • [37] Cells, Stem Cells, and Cancer Stem Cells
    Aguilar-Gallardo, Cristobal
    Simon, Carlos
    SEMINARS IN REPRODUCTIVE MEDICINE, 2013, 31 (01) : 5 - 13
  • [38] WNT5B in osteosarcoma stem cells
    Perkins, Rachel S.
    Suthon, Sarocha
    Miranda-Carboni, Gustavo A.
    Krum, Susan A.
    CANCER RESEARCH, 2022, 82 (12)
  • [39] Role of proteoglycan synthesis genes in osteosarcoma stem cells
    Osumi, Ryoma
    Sugihara, Kengo
    Yoshimoto, Makoto
    Tokumura, Kazuya
    Tanaka, Yuki
    Hinoi, Eiichi
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [40] The emerging role of lncRNAs in the regulation of osteosarcoma stem cells
    Song, X-J
    Bi, M-C
    Zhu, Q-S
    Liu, X-L
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (03) : 966 - 974
12345